• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部皮肤利什曼病病灶内锑剂治疗后结节性淋巴管炎皮下播散

Nodular lymphangitic subcutaneous dissemination after intralesional antimonial treatment for localized cutaneous leishmaniasis.

作者信息

Yébenes M, Cruz I, Cañavate C, Gilaberte M, Baena V, Pujol R M

机构信息

Department of Dermatology, Hospital del March, IMAS, Barcelona, Spain.

出版信息

Clin Exp Dermatol. 2008 Mar;33(2):142-4. doi: 10.1111/j.1365-2230.2007.02575.x. Epub 2007 Dec 10.

DOI:10.1111/j.1365-2230.2007.02575.x
PMID:18076691
Abstract

Human leishmaniases are protozoan diseases with diverse clinical features. They are transmitted by the bites of the Phlebotomus sand fly, and the reservoirs are usually wild and domestic animals, particularly dogs. In Spain, Leishmania infantum is the causative agent of both cutaneous and visceral leishmaniasis. Cutaneous leishmaniasis is a parasitic disease occurring throughout the Americas and in the Old World, particularly the Middle East and North Africa. It is spread by the female sandfly. We report a 33-year-old man who presented with a solitary plaque on the right elbow, which was found to contain Leishmania bodies. He was treated with intralesional meglumine antimoniate, but 2 weeks later, several subcutaneous nodules were noted on the inner right arm. PCR identified the organism as L. infantum. The patient was treated with itraconazole (200 mg/day) for 6 weeks was prescribed, which resulted in marked clinical improvement in the elbow plaque. However, because of the persistence and lack of response of the other lesions, systemic treatment with meglumine antimoniate (20 mg/kg/day) intravenously for 7 days and intramuscularly for 13 days was administered. A progressive improvement in both cutaneous and subcutaneous lesions was achieved, and the lesions resolved completely after 2 months.

摘要

人类利什曼病是具有多种临床特征的原生动物疾病。它们通过白蛉叮咬传播,宿主通常是野生动物和家畜,尤其是狗。在西班牙,婴儿利什曼原虫是皮肤利什曼病和内脏利什曼病的病原体。皮肤利什曼病是一种在美洲以及东半球,特别是中东和北非地区流行的寄生虫病。它由雌性白蛉传播。我们报告了一名33岁男性,其右肘部出现一个孤立斑块,经检查发现含有利什曼原虫体。他接受了病灶内注射葡甲胺锑酸盐治疗,但2周后,右上肢内侧出现了几个皮下结节。聚合酶链反应鉴定该病原体为婴儿利什曼原虫。患者接受了为期6周的伊曲康唑(200毫克/天)治疗,肘部斑块有明显临床改善。然而,由于其他病灶持续存在且无反应,给予了为期7天的静脉注射和为期13天的肌肉注射葡甲胺锑酸盐(20毫克/千克/天)进行全身治疗。皮肤和皮下病灶均逐渐改善,2个月后病灶完全消退。

相似文献

1
Nodular lymphangitic subcutaneous dissemination after intralesional antimonial treatment for localized cutaneous leishmaniasis.局部皮肤利什曼病病灶内锑剂治疗后结节性淋巴管炎皮下播散
Clin Exp Dermatol. 2008 Mar;33(2):142-4. doi: 10.1111/j.1365-2230.2007.02575.x. Epub 2007 Dec 10.
2
Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major.局部用硫酸巴龙霉素(每日两次)与病灶内注射葡甲胺锑酸盐治疗硕大利什曼原虫引起的皮肤利什曼病的比较。
Eur J Dermatol. 2005 Mar-Apr;15(2):85-7.
3
Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.比较局部用巴龙霉素与病灶内注射葡甲胺锑酸盐治疗皮肤利什曼病的疗效。
Int J Dermatol. 2005 Dec;44(12):1064-5. doi: 10.1111/j.1365-4632.2004.02597.x.
4
Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis.病灶内注射葡甲胺锑酸盐、冷冻疗法及其联合应用治疗皮肤利什曼病的比较。
Int J Dermatol. 2006 Sep;45(9):1115-6. doi: 10.1111/j.1365-4632.2006.02822.x.
5
Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.一名感染HIV的患者出现类似黑热病后皮肤利什曼病的非典型播散性利什曼病。
Int J STD AIDS. 2006 May;17(5):351-3. doi: 10.1258/095646206776790132.
6
Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.阿奇霉素与葡甲胺锑酸盐(葡糖胺锑钠)治疗皮肤利什曼病的疗效比较
Am J Trop Med Hyg. 2007 Jul;77(1):99-101.
7
The in vivo activity of 1,3,4-thiadiazolium-2-aminide compounds in the treatment of cutaneous and visceral leishmaniasis.1,3,4-噻二唑-2-氨基化合物在治疗皮肤利什曼病和内脏利什曼病中的体内活性。
J Antimicrob Chemother. 2012 Jan;67(1):182-90. doi: 10.1093/jac/dkr409. Epub 2011 Oct 10.
8
A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.标准剂量或低剂量的葡甲胺锑酸盐全身治疗联合口服奥美拉唑治疗皮肤利什曼病的疗效比较研究。
J Vector Borne Dis. 2008 Dec;45(4):287-91.
9
Leishmaniasis of the lip in a patient with Down's syndrome.一名唐氏综合征患者唇部的利什曼病。
J Eur Acad Dermatol Venereol. 2004 Sep;18(5):599-602. doi: 10.1111/j.1468-3083.2004.00987.x.
10
Cytogenetic observations after meglumine antimoniate therapy for visceral leishmaniasis.葡甲胺锑酸盐治疗内脏利什曼病后的细胞遗传学观察
Pharmacotherapy. 1996 Sep-Oct;16(5):869-71.